Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill
Novo Nordisk(US:NVO) The Motley Fool·2025-12-23 21:42On Dec. 23, 2025, investors weighed a newly approved oral obesity pill’s first-mover edge and its ripple effects across healthcare.NYSE : NVONovo NordiskToday's Change( 7.42 %) $ 3.57Current Price$ 51.67Key Data PointsMarket Cap$162BDay's Range$ 51.05 - $ 53.2052wk Range$ 43.08 - $ 93.80Volume2.1MAvg Vol16MGross Margin81.93 %Dividend Yield3.59 %Novo Nordisk (NVO +7.42%), which develops and markets diabetes and obesity treatments, closed Tuesday’s session at $51.61, up 7.30% after U.S. approval of its once-d ...